Glucotrack, Inc. current report, 07 July 2016

Business Context and Reporting Period

This Form 8-K was filed by Integrity Applications, Inc. on July 7, 2016, reporting events that occurred on June 30, 2016. The filing details the fourth closing of a private placement offering of Series C Convertible Preferred Stock and associated warrants to accredited investors.

Key Financial Metrics

  • Gross Proceeds: $1,050,650 raised from the sale of 1,050.65 Units.
  • Capital Structure Impact: Issuance of 1,050.65 shares of Series C 5.5% Convertible Preferred Stock.
  • Conversion Terms: Preferred Stock is convertible into an aggregate of 233,480 shares of Common Stock at an initial price of $4.50 per share.
  • Warrant Issuance: Two classes of 5-year warrants issued per Unit:
    • Series C-1 Warrants: Exercise price of $4.50 per share.
    • Series C-2 Warrants: Exercise price of $7.75 per share.
  • Total Potential Dilution: Warrants are exercisable for an aggregate of 466,960 shares of Common Stock.
  • Placement Agent Compensation: 10% commission plus 3% expense allowance paid in cash; additional warrants issued for 46,696 shares at $4.50 and 23,348 shares at $7.75.

Note: This filing does not provide data on revenue, operating profit, cash flow, margins, or existing debt levels.

Material Changes

This transaction represents the fourth closing of an ongoing offering. Previous closings occurred on April 14, 2016, May 4, 2016, and June 6, 2016, involving a total of 3,374.5 Units. The terms of the Preferred Stock and Warrants in this closing are identical to those in the prior issuances.

Outlook, Risks, and Contingencies

  • Registration Rights: The Company entered into a Registration Rights Agreement with the purchasers, substantially identical to agreements with prior investors.
  • Anti-Dilution Protection: Warrants issued to the Placement Agent include full ratchet anti-dilution protection and cashless exercise options, which may differ from investor warrants.
  • Regulatory Status: Securities were sold unregistered under Section 4(a)(2) of the Securities Act of 1933 to accredited investors only.

Investor Verification Checklist

  • Verify the total aggregate capital raised across all four closings of this offering series.
  • Review the full text of the Securities Purchase Agreement (Exhibit 4.1) for specific conversion adjustment mechanisms.
  • Assess the impact of the Placement Agent's full ratchet anti-dilution protection on future equity valuations.
  • Confirm the Company's current cash position and runway following the receipt of $1,050,650 in gross proceeds.
  • Check for any subsequent filings regarding the registration of the underlying common stock.